CBRE GROUP INC - A (CBRE) Fundamental Analysis & Valuation

NYSE:CBRE • US12504L1098

Current stock price

131.99 USD
-1.22 (-0.92%)
At close:
132.99 USD
+1 (+0.76%)
After Hours:

This CBRE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. CBRE Profitability Analysis

1.1 Basic Checks

  • CBRE had positive earnings in the past year.
  • In the past year CBRE had a positive cash flow from operations.
  • CBRE had positive earnings in each of the past 5 years.
  • CBRE had a positive operating cash flow in each of the past 5 years.
CBRE Yearly Net Income VS EBIT VS OCF VS FCFCBRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

1.2 Ratios

  • CBRE has a better Return On Assets (3.75%) than 85.71% of its industry peers.
  • The Return On Equity of CBRE (13.03%) is better than 93.65% of its industry peers.
  • CBRE has a better Return On Invested Capital (5.08%) than 74.60% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CBRE is in line with the industry average of 5.50%.
Industry RankSector Rank
ROA 3.75%
ROE 13.03%
ROIC 5.08%
ROA(3y)4.03%
ROA(5y)5.45%
ROE(3y)12.16%
ROE(5y)15.19%
ROIC(3y)6.32%
ROIC(5y)7.21%
CBRE Yearly ROA, ROE, ROICCBRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • With a decent Profit Margin value of 2.85%, CBRE is doing good in the industry, outperforming 65.08% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CBRE has declined.
  • CBRE has a Operating Margin of 3.19%. This is comparable to the rest of the industry: CBRE outperforms 55.56% of its industry peers.
  • In the last couple of years the Operating Margin of CBRE has declined.
  • CBRE has a Gross Margin (18.66%) which is comparable to the rest of the industry.
  • CBRE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.19%
PM (TTM) 2.85%
GM 18.66%
OM growth 3Y-9.5%
OM growth 5Y-5.5%
PM growth 3Y-14.49%
PM growth 5Y-2%
GM growth 3Y-3.73%
GM growth 5Y-1.09%
CBRE Yearly Profit, Operating, Gross MarginsCBRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. CBRE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CBRE is destroying value.
  • Compared to 1 year ago, CBRE has less shares outstanding
  • Compared to 5 years ago, CBRE has less shares outstanding
  • Compared to 1 year ago, CBRE has a worse debt to assets ratio.
CBRE Yearly Shares OutstandingCBRE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
CBRE Yearly Total Debt VS Total AssetsCBRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • An Altman-Z score of 3.02 indicates that CBRE is not in any danger for bankruptcy at the moment.
  • With a decent Altman-Z score value of 3.02, CBRE is doing good in the industry, outperforming 68.25% of the companies in the same industry.
  • CBRE has a debt to FCF ratio of 6.56. This is a slightly negative value and a sign of low solvency as CBRE would need 6.56 years to pay back of all of its debts.
  • CBRE has a better Debt to FCF ratio (6.56) than 69.84% of its industry peers.
  • CBRE has a Debt/Equity ratio of 0.87. This is a neutral value indicating CBRE is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.87, CBRE is not doing good in the industry: 60.32% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 6.56
Altman-Z 3.02
ROIC/WACC0.59
WACC8.63%
CBRE Yearly LT Debt VS Equity VS FCFCBRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.3 Liquidity

  • CBRE has a Current Ratio of 1.09. This is a normal value and indicates that CBRE is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.09, CBRE is doing worse than 71.43% of the companies in the same industry.
  • CBRE has a Quick Ratio of 1.09. This is a normal value and indicates that CBRE is financially healthy and should not expect problems in meeting its short term obligations.
  • CBRE has a Quick ratio of 1.09. This is in the lower half of the industry: CBRE underperforms 68.25% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.09
CBRE Yearly Current Assets VS Current LiabilitesCBRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. CBRE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 25.05% over the past year.
  • The Earnings Per Share has been growing by 14.27% on average over the past years. This is quite good.
  • The Revenue has grown by 13.38% in the past year. This is quite good.
  • CBRE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.22% yearly.
EPS 1Y (TTM)25.05%
EPS 3Y4%
EPS 5Y14.27%
EPS Q2Q%17.67%
Revenue 1Y (TTM)13.38%
Revenue growth 3Y9.57%
Revenue growth 5Y11.22%
Sales Q2Q%11.77%

3.2 Future

  • The Earnings Per Share is expected to grow by 16.85% on average over the next years. This is quite good.
  • Based on estimates for the next years, CBRE will show a quite strong growth in Revenue. The Revenue will grow by 9.11% on average per year.
EPS Next Y18.69%
EPS Next 2Y17.39%
EPS Next 3Y16.01%
EPS Next 5Y16.85%
Revenue Next Year11.85%
Revenue Next 2Y10.44%
Revenue Next 3Y9.9%
Revenue Next 5Y9.11%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CBRE Yearly Revenue VS EstimatesCBRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
CBRE Yearly EPS VS EstimatesCBRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. CBRE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 20.66, CBRE is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Earnings ratio of CBRE indicates a somewhat cheap valuation: CBRE is cheaper than 73.02% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.23. CBRE is around the same levels.
  • Based on the Price/Forward Earnings ratio of 17.40, the valuation of CBRE can be described as rather expensive.
  • 84.13% of the companies in the same industry are more expensive than CBRE, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 23.28. CBRE is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 20.66
Fwd PE 17.4
CBRE Price Earnings VS Forward Price EarningsCBRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CBRE is valued a bit cheaper than the industry average as 69.84% of the companies are valued more expensively.
  • 68.25% of the companies in the same industry are more expensive than CBRE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 32.66
EV/EBITDA 19.28
CBRE Per share dataCBRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • CBRE has a very decent profitability rating, which may justify a higher PE ratio.
  • CBRE's earnings are expected to grow with 16.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.11
PEG (5Y)1.45
EPS Next 2Y17.39%
EPS Next 3Y16.01%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CBRE Dividend Analysis

5.1 Amount

  • No dividends for CBRE!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CBRE Fundamentals: All Metrics, Ratios and Statistics

CBRE GROUP INC - A

NYSE:CBRE (3/20/2026, 8:04:00 PM)

After market: 132.99 +1 (+0.76%)

131.99

-1.22 (-0.92%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)02-12
Earnings (Next)04-22
Inst Owners99.07%
Inst Owner Change0.57%
Ins Owners0.63%
Ins Owner Change4.48%
Market Cap38.96B
Revenue(TTM)40.55B
Net Income(TTM)1.16B
Analysts83
Price Target189.93 (43.9%)
Short Float %1.35%
Short Ratio1.73
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.98%
Min EPS beat(2)0.04%
Max EPS beat(2)7.92%
EPS beat(4)4
Avg EPS beat(4)6.74%
Min EPS beat(4)0.04%
Max EPS beat(4)10.42%
EPS beat(8)8
Avg EPS beat(8)7.13%
EPS beat(12)12
Avg EPS beat(12)7.3%
EPS beat(16)15
Avg EPS beat(16)8.79%
Revenue beat(2)0
Avg Revenue beat(2)-1.69%
Min Revenue beat(2)-2.6%
Max Revenue beat(2)-0.77%
Revenue beat(4)1
Avg Revenue beat(4)-1.05%
Min Revenue beat(4)-2.6%
Max Revenue beat(4)1.13%
Revenue beat(8)2
Avg Revenue beat(8)-0.93%
Revenue beat(12)6
Avg Revenue beat(12)0.55%
Revenue beat(16)7
Avg Revenue beat(16)-0.24%
PT rev (1m)-1.28%
PT rev (3m)1.08%
EPS NQ rev (1m)6.31%
EPS NQ rev (3m)3.48%
EPS NY rev (1m)0.84%
EPS NY rev (3m)1.06%
Revenue NQ rev (1m)4.31%
Revenue NQ rev (3m)4.31%
Revenue NY rev (1m)1.91%
Revenue NY rev (3m)2.06%
Valuation
Industry RankSector Rank
PE 20.66
Fwd PE 17.4
P/S 0.96
P/FCF 32.66
P/OCF 24.99
P/B 4.39
P/tB N/A
EV/EBITDA 19.28
EPS(TTM)6.39
EY4.84%
EPS(NY)7.58
Fwd EY5.75%
FCF(TTM)4.04
FCFY3.06%
OCF(TTM)5.28
OCFY4%
SpS137.39
BVpS30.08
TBVpS-3.88
PEG (NY)1.11
PEG (5Y)1.45
Graham Number65.76
Profitability
Industry RankSector Rank
ROA 3.75%
ROE 13.03%
ROCE 6.97%
ROIC 5.08%
ROICexc 5.57%
ROICexgc 11.69%
OM 3.19%
PM (TTM) 2.85%
GM 18.66%
FCFM 2.94%
ROA(3y)4.03%
ROA(5y)5.45%
ROE(3y)12.16%
ROE(5y)15.19%
ROIC(3y)6.32%
ROIC(5y)7.21%
ROICexc(3y)6.87%
ROICexc(5y)8.07%
ROICexgc(3y)14.53%
ROICexgc(5y)18.56%
ROCE(3y)8.23%
ROCE(5y)9.39%
ROICexgc growth 3Y-21.33%
ROICexgc growth 5Y-6.1%
ROICexc growth 3Y-16.05%
ROICexc growth 5Y-7%
OM growth 3Y-9.5%
OM growth 5Y-5.5%
PM growth 3Y-14.49%
PM growth 5Y-2%
GM growth 3Y-3.73%
GM growth 5Y-1.09%
F-Score5
Asset Turnover1.31
Health
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 6.56
Debt/EBITDA 3.46
Cap/Depr 39.44%
Cap/Sales 0.9%
Interest Coverage 2.89
Cash Conversion 70.19%
Profit Quality 103.11%
Current Ratio 1.09
Quick Ratio 1.09
Altman-Z 3.02
F-Score5
WACC8.63%
ROIC/WACC0.59
Cap/Depr(3y)44.67%
Cap/Depr(5y)43.27%
Cap/Sales(3y)0.91%
Cap/Sales(5y)0.86%
Profit Quality(3y)88.53%
Profit Quality(5y)96.03%
High Growth Momentum
Growth
EPS 1Y (TTM)25.05%
EPS 3Y4%
EPS 5Y14.27%
EPS Q2Q%17.67%
EPS Next Y18.69%
EPS Next 2Y17.39%
EPS Next 3Y16.01%
EPS Next 5Y16.85%
Revenue 1Y (TTM)13.38%
Revenue growth 3Y9.57%
Revenue growth 5Y11.22%
Sales Q2Q%11.77%
Revenue Next Year11.85%
Revenue Next 2Y10.44%
Revenue Next 3Y9.9%
Revenue Next 5Y9.11%
EBIT growth 1Y-15.16%
EBIT growth 3Y-0.84%
EBIT growth 5Y5.11%
EBIT Next Year51.3%
EBIT Next 3Y23.17%
EBIT Next 5Y16.26%
FCF growth 1Y-14.85%
FCF growth 3Y-4.48%
FCF growth 5Y-5.27%
OCF growth 1Y-8.72%
OCF growth 3Y-1.46%
OCF growth 5Y-3.16%

CBRE GROUP INC - A / CBRE Fundamental Analysis FAQ

What is the fundamental rating for CBRE stock?

ChartMill assigns a fundamental rating of 5 / 10 to CBRE.


What is the valuation status of CBRE GROUP INC - A (CBRE) stock?

ChartMill assigns a valuation rating of 5 / 10 to CBRE GROUP INC - A (CBRE). This can be considered as Fairly Valued.


What is the profitability of CBRE stock?

CBRE GROUP INC - A (CBRE) has a profitability rating of 6 / 10.


Can you provide the expected EPS growth for CBRE stock?

The Earnings per Share (EPS) of CBRE GROUP INC - A (CBRE) is expected to grow by 18.69% in the next year.